Facente SN

Use of HIV recency assays for HIV incidence estimation and non-incidence surveillance use cases: a systematic review
Facente SN, Agyei L, Maher AD, Mahy M, Dalal S, Lowrance D, Grebe PE, Marsh K

medRxiv

(2021)

https://doi.org/10.1101/2021.08.23.21262504
Estimated dates of detectable infection (EDDIs) as an improvement upon Fiebig staging for HIV infection dating
Facente SN, Grebe PE, Pilcher CD, Busch MP, Murphy G, Welte A

Epidemiology and Infection

(2020)

https://doi.org/10.1017/S0950268820000503
Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool
Grebe PE, Facente SN, Bingham JL, Pilcher CD, Powrie A, Gerber J, Priede G, Chibawara T, Busch MP, Murphy G, Kassanjee R, Welte A

BMC Infectious Diseases

(2019)

https://doi.org/10.1186/s12879-019-4543-9
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance
Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Pilcher CD, Murphy G, Grebe PE

PLoS One

(2019)

https://doi.org/10.1101/572677
A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results
Pilcher C, Porco TC, Facente SN, Grebe PE, Delaney KP, Silvina M, Kassanjee R, Busch MP, Murphy G, Owen SM, Welte A

AIDS

(2019)

https://doi.org/10.1097/QAD.0000000000002190
Challenges to the performance of current HIV diagnostic assays and the need for centralized specimen archives: a review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) repository [version 1; peer review: 3 approved, 1 approved with reservations].
Facente SN, Busch MP, Grebe PE, Pilcher CE, Welte A, Rice B, Murphy G

Gates Open Research

(2019)

https://doi.org/10.12688/gatesopenres.13048.1
Infection staging and incidence surveillance applications of high dynamic range diagnostic immuno-assay platforms
Grebe PE, Welte A, Hall J, Keating SM, Facente SN, Marson K, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD, Murphy G

Journal of Acquired Immune Deficiency Syndromes

(2017)

https://doi.org/10.1097/QAI.0000000000001537
HIV antibody level as a marker of HIV persistence and low-level viral replication
Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht FM, Deeks SG, Pillai SK, Busch MP

The Journal of Infectious Diseases

(2017)

https://doi.org/10.1093/infdis/jix225
Moving towards a reliable HIV incidence test-current status, resources available, future directions and challenges ahead
Murphy G, Pilcher CD, Keating SM, Kassanjee R, Facente SN, Welte A, Grebe PE, Marson K, Busch MP, Dailey P, Parkin N, Osborn J, Ongarello S, Marsh K, Garcia Calleja JM

Epidemiology and Infection

(2017)

https://doi.org/10.1017/S0950268816002910
Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma
Schlusser KE, Pilcher CD, Kallas EG, Santos BR, Deeks SG, Facente SN, Keating SM, Busch MP, Murphy G, Welte A, Quinn TC, Eshleman SH, Laeyendecker O

PLoS One

(2017)

https://doi.org/10.1371/journal.pone.0172283
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
Price MA, Martin JN, Little S, Hecht FM, Kassanjee R, Kallas EG, Welte A, Murphy G, Busch MP, Keating SM, Pilcher CD, Facente SN, McKinney E

AIDS

(2014)

https://doi.org/10.1097/QAD.0000000000000429